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Background: In recent years, most Dutch general practitioners started working under the umbrella of diabetes care
groups, responsible for the organisation and coordination of diabetes care. The quality management of these new
organisations receives growing interest, although its association with quality of diabetes care is yet unclear. The
best way to measure quality management is unknown and it has not yet been studied at the level of outpatient
clinics or care groups. We aimed to assess quality management of type 2 diabetes care in care groups and
outpatient clinics.
Results: Quality management was measured with online questionnaires, containing six domains (see below). They
were divided into 28 subdomains, with 59 (care groups) and 57 (outpatient clinics) questions respectively. The
mean score of the domains reflects the overall score (0-100%) of an organisation. Two quality managers of all
Dutch care groups and outpatient clinics were invited to fill out the questionnaire.
Sixty care groups (response rate 61.9%) showed a mean score of 59.6% (CI 57.1-62.1%). The average score in 52
outpatient clinics (response rate 50.0%) was 61.9% (CI 57.5-66.8%).
Mean scores on the six domains for care groups and outpatient clinics respectively were: ‘organisation of care’
71.9% (CI 68.8-74.9%), 76.8% (CI 72.8-80.7%); ‘multidisciplinary teamwork’ 67.1% (CI 62.4-71.9%), 71.5% (CI 65.3-77.8%);
‘patient centeredness’ 46.7% (CI 42.6-50.7%), 62.5% (CI 57.7-67.2%); ‘performance management’ 63.3% (CI 61.2-65.3%),
50.9% (CI 44.2-57.5%); ‘quality improvement policy’ 52.6% (CI 49.2-56.1%), 50.9% (CI 44.6-57.3%); and ‘management
strategies’ 56.0% (CI 51.4-60.7%), 59.0% (CI 52.8-65.2%). On subdomains, care groups scored highest on ‘care program’
(83.3%) and ‘measured outcomes’ (98.3%) and lowest on ‘patient safety’ (15.1%) and ‘patient involvement’ (17.7%).
Outpatient clinics scored high on the presence of a ‘diabetic foot team’ (81.6%) and the support in ‘self-management’
(81.0%) and low on ‘patient involvement’ (26.8%) and ‘inspection of medical file’ (28.0%).
Conclusions: This nationwide assessment reveals that the level of quality management in diabetes care varies between
several subdomains in both diabetes care groups and outpatient clinics.
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An increasing number of health care providers are in-
volved in diabetes care. Consequently, optimal colla-
boration among professionals has become essential for
delivering high quality of care [1]. This has led to the
development of multidisciplinary diabetes teams using
disease management programs. Besides monitoring patient* Correspondence: M.J.E.Campmans-Kuijpers@UmcUtrecht.nl
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article, unless otherwise stated.related outcomes and process indicators (reflecting actions
of health care professionals), quality management (QM)
on an organisational level is receiving growing interest in
order to maintain or enhance the delivery of good quality
diabetes care [2].
In the Netherlands, with a type 2 diabetes prevalence
of 5%, 85-90% of all patients with type 2 diabetes are
treated by general practitioners in a primary care setting
[3,4]. In recent years, most general practitioners started
working under the umbrella of diabetes care groups
(DCGs). These DCGs are comparable with accountableMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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commission groups in the United Kingdom [7]. As the
main contractor of a diabetes care program, DCGs are
responsible for the organisation and coordination of dia-
betes care [8,9]. Apart from general practitioners, DCGs
contract other health providers like podiatrists and dieti-
cians. Their diabetes care program is based on the Dutch
Diabetes Federation Health Care Standard for type 2 dia-
betes [10]. In 2011, 97 DCGs, with on average 81 general
practitioners [11], were treating 170–23,000 diabetes pa-
tients per DCG [4]. In 2010, 15% of all patients in pri-
mary care were not treated in a DCG [4]. Patients who
need more complex diabetes care are treated by endo-
crinologists in 104 diabetes outpatient clinics (DOCs)
[4]. Endocrinologists hold the final responsibility for a
diabetes team, consisting of endocrinologists, diabetes
nurses, dieticians, and a special team for the treatment
of a diabetic foot [12]. Each DOC treats between 250
and 4,500 diabetes patients. Besides the Dutch diabetes
standard, they have special guidelines for treatment of a
diabetic foot, retinopathy, and nephropathy [12,13].
Both DOCs and DCGs need quality management to
control the complex diabetes care processes. Quality man-
agement comprises procedures to monitor, assess, and
improve the quality of care [14]. Validated measures with
regard to quality management are lacking. Quality im-
provement strategies mainly address the individual profes-
sional or patient level and generally focus on process and
outcomes measures. However, it might be important to
focus on the structural or organisational level of diabetes
care as well. A meta-analysis of quality improvement strat-
egies showed that interventions upon the entire system of
chronic disease management, like team changes, case
management, continuous quality improvement, or elec-
tronic patient registry were in fact associated with the lar-
gest effects on HbA1c, irrespective of baseline HbA1c. On
the contrary, the effectiveness of interventions targeting
individual health care providers and patients seem to vary
with baseline HbA1c. Therefore, quality management
targeting the entire system should be included in quality
improvement strategies for diabetes care [15], which
means that these strategies should not only focus on
education of the individual health care provider or pa-
tient, but address several aspects of the organisation as
a whole (see Figure 1). On the other hand a systematic
review found that structure indicators, measuring e.g.
the adequacy of facilities, equipment, logistics, or regis-
tration showed no associations with (surrogate) patient
outcomes [16]. Diabetes quality management at an or-
ganisational level has only been assessed at the hospital
level [14,17], but not yet at the DOC level. DCGs vary
widely with regard to the type of legal entity, the owner-
ship and the number of employees [9]. The develop-
ment of DCGs introduced a new management level ontop of the management of general practices. This study
aims to measure the level of diabetes quality manage-
ment in DCGs and DOCs across the Netherlands.
Methods
Study design
A cross-sectional measurement of the level of quality man-
agement in Dutch DCGs and DOCs was performed. No
ethical approval was needed, because this study does not
meet the criteria for medical human scientific research ac-
cording to the Dutch legislation [18].
Measurements
Based on literature we developed two online questionnaires
for quality management for DCGs and DOCs separately.
The questionnaires contained six domains: 1.‘organisation
of care’; 2. ‘multidisciplinary teamwork’; 3. ‘patient cen-
teredness’; 4. ‘performance management’; 5. ‘quality im-
provement policy’; and 6. ‘management strategies’. Each
domain contained subdomains, in total 28 subdomains
were addressed with one to six questions; the total num-
ber of questions amounts to 59 for DCGs and 57 for
DOCs. In the DCG questionnaire, the diabetic foot team
was left out. The DOC questionnaire contained a looping
to prevent posing irrelevant questions. Both the score in
the domains and subdomains range from 0 to 100%. De-
tails of the development of the questionnaires have been
described elsewhere [19] and can be found in Additional
files 1 and 2 (in Dutch).
First, all organisations were asked who were the two
people mainly responsible for quality management
within the organisation. In January 2012, these people of
all DCGs (n = 97) and DOCs (n = 104) were invited to fill
out the questionnaire. After two and four weeks re-
minders were sent.
To study whether results are generalizable, non-
responders were asked how many patients were enrolled
in their diabetes program and how non-responders judged
their level of quality management. For this judgment a
multiple choice question was used with the following op-
tions: 1. insufficiently developed; 2. under development; 3.
well developed; and 4. excellently developed, including a
cyclic quality management policy. From non-responders
who also did not respond to this question we retrieved the
number of patients treated from the national website
about healthcare organisations in the Netherlands [20].
Scoring of the questionnaires
Scoring on question level
Each question had a maximum score of one point [21].
Since there were different types of questions, different
scores were used. Some questions had X subquestions; each
subquestion could count for a maximum score of 1/X. Fur-
thermore, the score was higher when the developmental
Figure 1 Quality management.
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scored zero points, if they had no policy on an item. If they
were developing a policy, the score was 0.33 points; if they
had an implemented policy, they scored 0.66 points and if
this policy was periodically evaluated, the score was one
point. In questions in which we assessed the number of
care providers involved in a particular item, each involved
care provider scored 1/Y to the maximum score of one
point. In the latter type of question the maximum score
could be reached when a defined number (Y) of care pro-
viders was involved.
Scoring of subdomains
Each subdomain consisted of one up to six questions.
The maximum score of a subdomain was 100 percent. If
a subdomain consisted of for example four questions, a
four point’s score was equal to 100 percent.
Scoring of domains
To weigh the importance of a subdomain within a do-
main, two expert panels, of DCGs and DOCs respectively,
were asked to weigh the subdomains. These weightings
showed significant differences between equal weighting of
each domain and the weight given by the expert panels
[Additional files 3 and 4] [19]. Therefore, all questions to-
gether within a subdomain contributed X percent to the
maximum score of a domain, where X was the mean
weight given by the corresponding expert panel. The mean
score of the six domains reflects the overall score inquality management of an organisation. Descriptive data
are presented as means (CI) and medians (IQR) if applic-
able. The complete scores of the questionnaires for DCGs
and DOCs can be found in Additional files 3 and 4
respectively.
Statistical analysis
To test the representativeness of the participating organi-
sations, their number of patients treated was compared
with the number of patients treated by non-responders
(independent t-test). Besides, their self-assessed level of
quality management was described.
By inviting two responders of each organisation the
Cohen’s kappa, which measures the agreement between
two responders was calculated [22]. Since both question-
naires contained a wide variety of questions with three to
seven answering categories with on top of that multiple





The responders of 60 diabetes DCGs (response rate
61.9%) were managers (36%), quality employees (18%),
managing directors (9%), primary care physicians with
specialty in diabetes care (10%) and others (27%). Re-
sponders on behalf of 52 DOCs (response rate 50.0%)
were endocrinologists with specialty in diabetes care
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agers (7%) and unit leaders (5%). The number of diabetes
patients enrolled in DCGs varied between 170 and 23,000,
with a mean number of 6,270 (SD 5442); in DOCs the
numbers varied between 250 and 4,500; (mean 1,600,
SD 789).Diabetes care groups
DCGs had an overall mean quality management score of
59.6% (CI 57.1-62.1%) (Figure 2; Table 1) with the follow-
ing mean scores in the domains: ‘organisation of care’
71.9% (CI 68.8-74.9%), ‘multidisciplinary teamwork’ 67.1%
(CI 62.4-71.9%), ‘patient centeredness’ 46.7% (CI 42.6-
50.7%), ‘performance management’ 63.3% (CI 61.2-65.3%),
‘quality improvement policy’ 52.6% (CI 49.2-56.1%), and
‘management strategies’ 56.0% (CI 51.4-60.7%).
Results of the subdomains demonstrated that DCGs had
the highest scores on the ‘care program’ (83.3%; CI 80.7-
86.0%) and the ‘measured outcomes’ (98.3%; CI 96.0-
100.0%). However, they scored low on ‘patient safety’
(15.1%; CI 10.7-19.5%), and ‘patient involvement’ (17.7%;
CI 12.9-22.4%) (Table 1).Diabetes outpatient clinics
The overall mean score of the DOCs was 61.9% (CI 57.5-
66.8%) (Table 1). Their mean scores in the domains were:
‘organisation of care’ 76.8% (CI 72.8-80.7%); ‘multidiscip-
linary teamwork’ 71.5% (CI 65.3-77.8%); ‘patient centered-
ness’ 62.5% (CI 57.7-67.2%); ‘performance management’
50.9% (CI 44.2-57.5%); ‘quality improvement policy’ 50.9%
(CI 44.6-57.3%); and ‘management strategies’ 59.0% (52.8-
65.2%). DOCs scored high on the presence of a ‘diabetic
foot team’ (81.6%; CI 71.3-91.0%) and the support in ‘self-
management’ (81.0%; CI 72.4-89.5%). Their lowest scoresFigure 2 Quality management in diabetes care; score in
outpatient clinics and care groups.were on ‘patient involvement’ (26.8%; CI 19.0-34.7%), and
‘inspection of medical file’ (28.0%; CI 21.0-35.0%).
Representativeness
From 37 non-responding DCGs 19 answered the non-
response question. None reported its level of quality man-
agement as ‘insufficient’, six as ‘under development’, seven
as ‘good’, and six reported an ‘excellent cyclical quality man-
agement’. From 52 non-responding DOCs 30 responded
the non-response question. None described its level of
quality management as ‘insufficient’, ten as ‘under develop-
ment’, ten as ‘good’, and ten DOCs reported an ’excellent
cyclical quality management’. There was no difference in
the number of patients enrolled in the diabetes program
between participating and non-participating DCGs (mean
6,270 and 6,690 respectively; p = 0.93). Participating DOCs
were larger than non-participating (mean 1,600 and 1,257
respectively; p = 0.02).
Reliability of the questionnaire
In ten DCGs two responders filled out 59 questions and
196 subquestions. The average observed agreement re-
garding questions was 69.4% and 71.9% regarding sub-
questions. This results in Cohen’s kappa values of 0.69
and 0.72 respectively. The questionnaire for DOCs con-
taining 57 questions with 223 subquestions was filled
out by two persons in three DOCs. Their average ob-
served agreement level was 64.6% and 63.6% respect-
ively, resulting in Cohen’s kappa values of 0.65 and 0.64
respectively.
Discussion
This study provides a nation-wide overview of the level of
diabetes quality management in diabetes care organisa-
tions in the Netherlands. Since this is the first time quality
management at this level has been measured, neither a
realistic achievable minimum standard nor a benchmark is
available. The overall scores on quality management in
both types of organisations showed similar results, but the
scores on quality management vary between several sub-
domains in both diabetes care groups and outpatient
clinics.
DCGs scored high on ‘organisation of care’ and espe-
cially on ‘care program’. This result was not unexpected,
because this care program forms the basis of the delivery
of their diabetes care. The relatively high scores in ‘per-
formance management’ were not unexpected as well, as
process and outcome indicators are being used by insur-
ance companies and patient organisations as a measure
for quality of diabetes care delivered by DCGs. Besides,
diabetes care providers and DCGs themselves use the re-
sults for benchmarking of performance within the DCG.
The low score on ‘patient centeredness’ shows that at or-
ganisational level the DCGs’ priority is probably not
Table 1 The average quality management score on (sub)domains in care groups and outpatient clinics
Domains and subdomains Care groups (n = 60) Outpatient clinics (n = 52)
Mean (%) CI (%) Mean (%) CI (%)
Care program 83.3 80.7-86.0 77.6 73.0-82.2
Continuity and Coordination 65.8 61.0-70.5 76.2 71.6-80.8
Communication and Information 65.5 58.9-72.1 76.5 70.5-82.5
Organisation of care* 71.9 68.8-74.9 76.8 72.8-80.7
Work agreement 62.8 59.2-66.4 69.5 61.4-77.5
Tasks and responsibilities 71.1 64.4-77.8 78.6 72.6-84.5
Teamwork/consultation/shared education/guidelines 74.4 68.0-80.7 71.4 63.9-78.8
Transfer and referral 58.5 50.5-66.6 54.2 44.8-63.5
Diabetic foot team -† - 81.6 71.3-91.9
Multidisciplinary teamwork* 67.1 62.4-71.9 71.5 65.3-77.8
Self-management 67.9 58.9-76.9 81.0 72.4-89.5
Individual care plan 40.0 33.6-46.4 51.1 41.9-60.4
Policy on patient education 57.3 49.6-65.0 79.2 72.1-86.3
Inspection of medical file 40.4 33.2-47.6 28.0 21.0-35.0
Patient interests 58.2 53.1-63.2 78.1 73.0-83.3
Patient involvement 17.7 12.9-22.4 26.8 19.0-34.7
Patient centeredness* 46.7 42.6-50.7 62.5 57.7-67.2
Registering results 59.6 54.5-64.8 57.5 46.7-68.3
Control of results 31.5 25.8-37.2 39.1 29.9-48.2
Processing of results 71.4 66.6-76.1 49.0 41.0-56.9
Analysing results 51.0 46.9-55.1 33.3 24.7-42.0
Measured outcomes 98.3 96.0-100.0 68.8 69.0-77.6
Performance management* 63.3 61.2-65.3 50.9 44.2-57.5
Elements of quality improvement 44.5 38.7-50.3 58.5 49.8-67.3
Feedback/benchmark 71.3 66.6-76.1 43.3 34.3-52.4
Visitation 41.4 33.8-49.0 41.7 33.9-49.6
Education 71.6 66.5-76.6 62.8 53.1-72.6
Patient safety 15.1 10.7-19.5 64.8 57.9-71.6
Defining sub-groups 37.8 30.6-44.9 37.9 29.7-46.0
Quality improvement policy* 52.6 49.2-56.1 50.9 44.6-57.3
Structural policy 62.9 58.3-67.5 51.5 46.5-56.5
Quality system 36.4 28.3-44.5 63.6 48.8-78.4
Quality documents 55.2 48.5-61.9 67.7 60.2-75.2
Management strategies* 56.0 51.4-60.7 59.0 52.8-65.2
Mean total score: 59.6 57.1-62.1 61.9 57.5-66.8
*weighted average.
†Care groups do not have a diabetic foot team.
Campmans-Kuijpers et al. BMC Research Notes 2014, 7:497 Page 5 of 7
http://www.biomedcentral.com/1756-0500/7/497(yet) in this domain. Especially the score on ‘patient in-
volvement’ is low. Indeed patients hardly participate in
the decision making regarding content and organisation
of disease management within DCGs [23]. There is de-
bate on patient involvement in health care organisations
in other countries as well [24]. Apart from a low score
on ‘patient safety’, the care group expert panel alsoweighted this subdomain relatively low (Table 1). Unlike
hospital care, primary care has been found to be rela-
tively safe, although incidents do occur in this setting as
well [25]. Therefore, patient safety in primary care is
likely to receive less priority which might explain the
low scores and weighting on ‘patient safety’. One might
question whether this is justified or not.
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teamwork’ score high; especially the diabetic foot team is
well organised. In the Netherlands, people with prob-
lems with a diabetes ulcer or a diabetic foot should be
referred by general practitioners to DOCs. The last dec-
ade, much attention has been paid to the obligatory
presence of a diabetic foot team in all Dutch hospitals,
with obvious success in terms of avoided amputations
[26]. ‘Performance management’ scores low; control and
analysing of results need more attention. The lack of ap-
propriate electronic information systems in many Dutch
hospitals and the lack of consensus about a minimum
set of quality indicators for performance management
are likely the main reasons for this result. In 2012, the
Netherlands Association of Internal Medicine agreed on
a so called e-diabetes core dataset [27] and we may as-
sume that as a result more attention will be paid to ‘per-
formance management’ in the near future. The growing
role of health insurance companies requesting perform-
ance indicators will also be important in this respect.
To the best of our knowledge, this is the first time the
level of quality management has been measured in
DCGs and DOCs. If quality management at an organisa-
tional level is indeed as important as stated by Tricco
[15], our questionnaires might be a useful asset for other
diabetes organisations using a disease management pro-
gram, like accountable care organisations and clinical
commission groups. The main issues in quality manage-
ment for diabetes care are covered and the question-
naires could be used by similar organisations as a basis
for their quality improvement programs. However, the
proof of concept of quality management at an organisa-
tional level to improve diabetes patients’ outcomes in
the consulting rooms of the multidisciplinary diabetes
team has not yet been established.
A limitation typical of research with self-assessment
questionnaires is social desirability. To reduce this social
desirability, participating managers were guaranteed that
feedback would only be given on their personal email ad-
dress, thus giving them opportunity to hide this feedback.
Furthermore, selection bias may have occurred if organisa-
tions with lower levels on quality management were more
likely to participate, because they want to learn from this
study. On the other hand, organisations with higher levels
on quality management might be more willing to partici-
pate, as they are eager to learn or like to demonstrate their
good level of quality management. Our non-responder
question (which was also prone to social desirability)
showed equal proportions of organisations which de-
scribed their level of quality management as ‘under devel-
opment’ and organisations which described their level of
quality management as ‘an excellent cyclical management’
level in both DCGs and DOCs. Furthermore, there is no
difference in size between responding and non-respondingDCGs, but larger DOCs tend to participate more often.
Therefore, we think our data are representative for the
quality management level of organisations across the
Netherlands.
Another limitation regards the validity and reliability of
the questionnaire. Face and content validity were war-
ranted by scrutinising literature for management models
and comparing the relevant items from the different
models. Also experts from care groups and outpatient
clinics were involved in the development of the question-
naires. Next, the corresponding expert-panels weighed the
subdomains within a domain. In a pilot study, both draft
questionnaires were tested by four and five experts from
primary and secondary care respectively. Furthermore, the
agreement between two responders of the questionnaires
was tested by allowing two respondents of the same organ-
isation to fill out the same questionnaire independently
[21]. Although the agreement in the questionnaires could
only be tested in ten DCGs and three DOCs, and was
often filled out by different type of professionals, the agree-
ment seems to be acceptable. Construct validity was based
on literature and a review of seven models for quality man-
agement, resulting in the six domains for diabetes quality
management [28]. If the questionnaire were to be used for
further research, confirmatory factor analyses should be
performed. Criterion related validity could not be tested
since there were no comparable instruments available.
Participating managers were given feedback on their
level of quality management, thus enabling them to im-
prove it [19]. After one year, this level will be measured
again. If such an improvement can be achieved (albeit
not in a controlled way) and if we could demonstrate a
relationship between relevant outcomes of diabetes care
and quality management at the organisational level,
quality management may become an important instru-
ment in the negotiations between DCGs and DOCs on
the one hand and health insurance companies on the
other. Until now we can state that quality management
varies within DCGs and DOCs and varies between sev-
eral subdomains.Conclusions
This nationwide assessment reveals that the level of qual-
ity management in diabetes care varies between several
subdomains in both diabetes care groups and outpatient
clinics. To study whether quality management and quality
of care are associated, quality management and its change
needs to be studied further.Additional files
Additional file 1: Quality management questionnaire for diabetes
care groups [In Dutch].
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